Sunshine Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUNSHINE
SUNSHINE has twenty-nine approved drugs.
There are three tentative approvals on SUNSHINE drugs.
Summary for Sunshine
| US Patents: | 0 |
| Tradenames: | 25 |
| Ingredients: | 25 |
| NDAs: | 29 |
Drugs and US Patents for Sunshine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunshine | AZITHROMYCIN | azithromycin | TABLET;ORAL | 209045-001 | Dec 7, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sunshine | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 213032-003 | Jun 11, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sunshine | ARIPIPRAZOLE | aripiprazole | TABLET;ORAL | 213037-003 | Oct 2, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sunshine | DULOXETINE HYDROCHLORIDE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 212328-002 | Feb 11, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
